the-infoshop.com - The vertical markets research portal
View CartView Cart
Global Information, Inc.
US: +1-860-674-8796
EU: +32-2-535-7543
SG: +65-6223-2436
  Home | Category | Publishers | Custom Research | E-mail Alert | About Us | Contact Us | Site Map |
 

* View All Categories
View Conferences
Japanese Korean Chinese

Market Research Report

Drug Delivery Technologies: Nano-enabled Delivery Players, products & prospects to 2018

Published by Espicom Business Intelligence Contact us : +1-860-674-8796
Published 2009/06 Content info 106 Pages
Product code ES94091
Price From  US $ 1130 Order/Price list
US $ 1130 Hard Copy
US $ 1130 PDF by E-mail (Single User License)
Delivery Time
PDF by E-Mail
Approx. 1-2 business days
Hard Copy/CD-ROM
Approx. 3-4 business days
If you need expedited delivery, please call us.
Description TOC

Table of Contents

EXECUTIVE SUMMARY & INTRODUCTION

  • Overview of nanotechnology: past, present & future
  • Nanotechnology: motivators & resistors
  • Nanomedicines, formulations and product regeneration

NANOTECHNOLOGY IN DRUG DELIVERY

  • Core nanotechnology used by the pharma industry
  • Nano-engineered drugs
  • Nano-carriers: Dendrimer, liposome micelle and polymeric nanoparticle structures
  • Current therapeutic applications of nanotechnology in drug delivery
  • Leading brands that utilise nanotechnology delivery
  • Future commercial applications & opportunities

STRATEGIES OF DRUG DELIVERY COMPANIES

  • Leading nanotechnology drug delivery companies
  • Strategic development & commercialisation partnerships and joint ventures
  • Mergers, acquisitions, start-ups & spin offs
  • Intellectual property

THE CURRENT & FUTURE MARKET

  • Leading approved nano-enabled product sales 2009
  • Companies developing nano-enabled product sales 2009
  • Novel nano-enabled product sales 2018
  • Global nano-enabled product sales 2018

COMPETITOR ANALYSIS

Detailed analysis of leading companies covering:

  • Proprietary delivery technology
  • Applications in the pharma industry
  • Management/technical expertise
  • Competition within the delivery technology sector
  • Products in development/approved utilising the delivery technology
  • Sales forecasts of products using the delivery technology
  • Competitor ratio analysis

Companies analysed

  • Abraxis BioScience, Inc
  • Access Pharmaceuticals, Inc
  • AlphaRx Corporation
  • ALZA Corporation
  • Aphios Corporation
  • Applied Pharma Research S.A.
  • BioSante Pharmaceuticals, Inc
  • Calando Pharmaceuticals, Inc
  • Camurus A.B.
  • Cerulean Pharma, Inc
  • CytImmune Sciences, Inc
  • Elan Corporation, Plc
  • Enzon Pharmaceuticals, Inc.
  • Gilead Sciences, Inc
  • Introgen Therapeutics
  • Mersana Therapeutics
  • Nano Interface Technology
  • Nano S Biotechnology GmbH
  • NanoBio Corporation
  • NanoBioMagnetics, Inc
  • Nanobiotix, Inc
  • NanoCarrier, Inc
  • Nanotechnology Victoria, Ltd.
  • NanoMaterials Technology
  • Nanotherapeutics, Inc
  • Novavax, Inc.
  • SkyePharma, Plc
  • Spherics Pharmaceuticals, Inc
  • Starpharma Holdings, Ltd

APPENDICIES

  • Nanotechnology approved drug sales 2008-2018
  • Nanotechnology developmental drug sales 2008-2018
  • Key nanotechnology delivery companies by 2018
Related Report
Back to Top
Please inform me when related publications are released
InfoWatch

US: 1-860-674-8796 EU: 32-2-535-7543 SG: 65-6223-2436
The vertical markets research portal
© 2009, the-infoshop.com by Global Information, Inc. All rights reserved.